Buy Olin Corporation (OLN) And Tivity Health, Inc. (TVTY) Before Analysts Start Chasing Them Higher

10 analysts out of 17 Wall Street brokerage firms rate Olin Corporation (NYSE:OLN) as a Buy, while 1 see it as a Sell. The rest 6 describe it as a Hold. OLN stock traded higher to an intra-day high of $23.95. At one point in session, its potential discontinued and the price was down to lows at $23.34. Analysts have set OLN’s consensus price at $29.31, effectively giving it a 25.42% projection on returns. Should the projected estimates be met, then the stock will likely hit its highest price at $35 (up 49.76% from current price levels). OLN has a 11.6% ROE, lower than the 12.86% average for the industry. The average ROE for the sector is 8.49%.

It is expected that in Mar 2019 quarter OLN will have an EPS of $0.33, suggesting a 120% growth. For Jun 2019 is projected at $0.41. It means that there could be a -24.07% growth in the quarter. Yearly earnings are expected to rise by 6.86% to about $1.87. As for the coming year, growth will be about 37.43%, lifting earnings to $2.57. RSI after the last trading period was 38.81. OLN recorded a change of -3.79% over the past week and returned 11.34% over the last three months while the OLN stock’s monthly performance revealed a shift in price of -8.53%. The year to date (YTD) performance stands at 16.21%, and the bi-yearly performance specified an activity trend of -22.26% while the shares have moved -28.71% for the past 12 months.

Olin Corporation (OLN) currently trades at $23.37, which is lower by -2.42% its previous price. It has a total of 167.09 million outstanding shares, with an ATR of around 0.77. The company’s stock volume dropped to 1.2 million, worse than 2.34 million that represents its 50-day average. A 5-day decrease of about -3.79% in its price means OLN is now 16.21% higher on year-to-date. The shares have surrendered $43436.63 since its $34.42 52-week high price recorded on 22nd of May 2018. Overall, it has seen a growth rate of -28.71 over the last 12 months. The current price per share is $5.5 above the 52 week low of $17.87 set on 26th of December 2018.

Olin Corporation (NYSE:OLN)’s EPS was $0.4 as reported for the December quarter. In comparison, the same quarter a year ago had an EPS of $0.34. That means that its growth in general now stands at 18%. Therefore, a prediction of $0.34 given by the analysts brought a positive surprise of 18%. OLN Dec 19 quarter revenue was $1.64 billion, compared to $1.62 billion recorded in same quarter last year, giving it a 1% growth rate. The company’s $0.02 billion revenue growth that quarter surprised Wall Street and investors will need to consider this as they assess the stock.

Tivity Health, Inc. (NASDAQ:TVTY) shares depreciated -1.86% over the last trading period, taking overall 5-day performance up to -7.67%. TVTY’s price now at $17.93 is weaker than the 50-day average of $22.17. Getting the trading period increased to 200 days, the stock price was seen at $30.93 on average. The general public currently hold control of a total of 40.63 million shares, which is the number publicly available for trading. The total of shares that it has issued to investors is 41.07 million. The company’s management holds a total of 0.8%, while institutional investors hold about 0% of the remaining shares. TVTY share price finished last trade -14.01% below its 20 day simple moving average and its downbeat gap from 200 day simple moving average is -42.23%, while closing the session with -19.64% distance from 50 day simple moving average.

Tivity Health, Inc. (TVTY) shares were last observed trading -57.05% down since March 15, 2018 when the peak of $41.75 was hit. Last month’s price growth of -15.3% puts TVTY performance for the year now at -27.73%. Consequently, the shares price is trending higher by -1.16%, a 52-week worst price since Mar. 14, 2019. However, it is losing value with -47.5% in the last 6 months. From a technical perspective, it appears more likely that the stock will experience a Bull Run market as a result of the strong support seen recently between $17.51 and $17.72. The immediate resistance area is now $18.26 Williams’s %R (14) for TVTY moved to 98.19 while the stochastic %K points at 2.65.

TVTY’s beta is 1.07; meaning investors could reap higher returns, although it also poses higher risks. The company allocated $2.28 per share from its yearly profit to its outstanding shares. Its last reported revenue is $153.04 million, which was 10% versus $139.35 million in the corresponding quarter last year. The EPS for Dec 19 quarter came in at $0.73 compared to $0.41 in the year-ago quarter and had represented 78% year-over-year earnings per share growth. TVTY’s ROA is 16.8%, higher than the 5.14% industry average. Although a more robust percentage would be better, consideration is given to how well peers within the industry performed. Companies within the sector had an ROA of 10.6%.

Estimated quarterly earnings for Tivity Health, Inc. (NASDAQ:TVTY) are around $0.54 per share in three months through March with $0.58 also the estimate for June quarter of the fiscal year. It means the growth is estimated at 10.2% and 9.43%, respectively. Analysts estimate full-year growth to be -0.43%, the target being $2.33 a share. The upcoming year will see an increase in growth by percentage to 18.03%, more likely to see it hit the $2.75 per share. The firm’s current profit margin over the past 12 months is 16.3%. TVTY ranks higher in comparison to an average of 2.48% for industry peers; while the average for the sector is 1.56%.